Skip to main content
Log in

Rituximab beim nephrotischen Syndrom

Rituximab in nephrotic syndrome

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Rueth EM, Kemper MJ, Leumann EP et al. (2005) Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 147: 202–207

    Article  PubMed  Google Scholar 

  2. Kemper MJ, Kuwertz-Broeking E, Bulla M et al. (2004) Recurrence of severe steroid dependency in Ciclosporin A-treated childhood idiopathic nephrotic syndrome. Nephrol Dial Transplant 19: 1136–1141

    Article  PubMed  Google Scholar 

  3. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556–560

    Article  PubMed  Google Scholar 

  4. Kemper MJ, Zepf K, Klaassen I et al. (2005) Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. Am J Nephrol 25: 132–137

    Article  PubMed  Google Scholar 

  5. Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60: 242–247

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M.J. Kemper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemper, M. Rituximab beim nephrotischen Syndrom. Nephrologe 2, 204–205 (2007). https://doi.org/10.1007/s11560-007-0079-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-007-0079-x

Navigation